MASCC Study Group Leadership

To contact a Study Group Leader, search for their name in the member directory
For more information or questions, contact the MASCC office at [email protected]

The Antiemetics Study Group focuses on the management of nausea and vomiting induced by chemotherapy and radiotherapy. The group has produced Antiemetic Practice Guidelines, conducts research, and works to promote the transfer of knowledge from clinical trials to clinical practice.
Chair: Rita Wickham, PhD, RN, AOCN - United States
Vice-Chair: Florian Scotté, PhD - France

Bone and Musculoskeletal
The Bone and Musculoskeletal Study Group conducts research and develops guidelines for the prevention and treatment of skeletal complications of cancer and its treatments. Its members also work to increase awareness of these complications and increase knowledge about bone health.
Chair: Beatrice Edwards, MD - United States
Vice-Chair: Winston Tan, MSHPeD, MD - United States

The Education Study Group seeks to make patient education an integral part of supportive cancer care and to improve patient education in numerous countries and languages. Projects include the development and pilot testing of a patient guide and evaluating the effectiveness of patient education in several languages and cultural settings.
Chair: Paz Fernández-Ortega, RN, MSc, PhD - Spain
Vice-Chair: Manon Lemonde, PhD, RN - Canada
Vice-Chair: Judy Phillips, DNP, FNP-BC, AOCN - USA

Subgroup: Digital Health
Leadership:  Penelope Schofield, PhD - Australia, Ysabella Van Sebille, PhD, MD - Australia

The Fatigue Study Group’s primary goal is multidisciplinary research to understand fatigue mechanisms and the experience of fatigue from diagnosis through treatment, rehabilitation, survivorship, and the end of life. The group collaborates with other MASCC Study Groups on research and workshops.
Chair: Stephen Samuel, MPT, PhD, MMASCC, MISOO - India
Vice-Chair: Leorey N. Saligan, PhD, RN - United States

The Geriatrics Study Group promotes a focus on geriatric oncology within MASCC and serves as a resource for other MASCC Study Groups. It also promotes communication with other professional societies with an interest in geriatric oncology and supportive care. Goals include developing guidelines for managing cancer-treatment complications in older adults.
Chair: Sriram Yennu, MD – United States
Vice-Chair: Yogesh Bendale, MD – India

The Hemostasis Study Group seeks to provide guidance and guidelines to healthcare providers regarding bleeding and clotting complications in cancer patients from diagnosis to the end of life. Goals include an increased awareness of coagulation abnormalities across the cancer continuum and evidence-based treatments for patients with bleeding or clotting complications.
Chair: Carmen Escalante, MD  - United States
Vice-Chair: Thomas Butler, MD  - United States
Vice-Chair: Carme Font, MD - Spain

The Mucositis Study Group's main goal is to improve outcomes of patients with oral and gastrointestinal mucositis associated with anticancer therapies. The group comprises members of both MASCC and ISOO and aims to improve the design and conduct of clinical investigations, disseminate up-to-date educational information, and serve as a resource for other investigators, clinicians, and patients. 
Chair: Sharon Elad, DMD MSc - USA
Vice-Chair: Paolo Bossi, MD - Italy 
Vice-Chair: Karis Kin-Fong Cheng, PhD, RN - Singapore

Neurological Complications
The Neurological Complications Study Group helps to raise awareness about the frequency, importance, and complexity of central and peripheral nervous system injuries induced by cancer treatments. These include cognitive and affective impairments, neuroendocrine dysfunction, and neuropathy. The group seeks to develop assessment tools, serve as a resource for other professionals, and develop practice guidelines.
Chair: Maryam Lustberg, MD, MPH – United States (MASCC President Elect)
Vice-Chair: Kathryn J. Ruddy, MD, MPH – United States

Neutropenia, Infection & Myelosuppression
The Neutropenia, Infection, and Myelosuppression Study Group addresses common immune system adverse effects of cancer chemotherapies and promotes the development of guidelines, such as the International Pediatric Fever and Neutropenia Guideline for the empiric management of pediatric fever and neutropenia. The prevention of febrile neutropenia in adults is another important topic of interest and research.
Chair: Bernardo Rapoport, MD - South Africa
Vice-Chair: Tim Cooksley, MBChB (Hons), MRCP - United Kingdom

Subgroup: Immuno-Oncology
Leadership: Bernardo Rapoport, MD, MMED - South Africa, Mario Lacouture, MD - United States

Nutrition and Cachexia
The Nutrition and Cachexia Study Group encourages broad-based research and state-of-the-art clinical practice in all areas of clinical nutrition as it relates to cancer. The group promotes awareness of existing guidelines for nutritional support and appropriate use of palliative and therapeutic strategies for managing anorexia and weight loss in patients with advanced cancer. Nutrition-based complementary therapy is another focus of this group.
Chair: Egidio Del Fabbro, MD - United States
Vice-Chair: Tateaki Naito, MD - Japan

The Oncodermatology Study Group works to raise awareness of dermatological conditions in cancer patients and takes a leadership role in the emerging field of cancer-related skin toxicities management. Objectives include identifying new targets for treatment, developing management guidelines, and helping to educate patients about skin reactions. This Study Group also serves as a resource for multi-center clinical trials and translational studies.
Chair: Julie Ryan Wolf, PhD, MPH - United States
Vice-Chair: Corina van den Hurk, PhD - Netherlands

Oral Care
The Oral Care Study Group’s main goals are to enhance knowledge and develop guidelines regarding therapy-associated oral complications, such as xerostomia, dysgeusia, dysphagia, oral pain, fungal and viral infections, osteoradionecrosis, osteonecrosis, dental disease, and trismus. The Study Group comprises members of both MASCC and ISOO who are working together on reviewing the incidence and prevalence of oral complications, their management, effects on quality life, and economic impact. 
Chair: Cherry L. Estilo, DDS - United States
Vice-Chair: Suzanne Carlisle, DDS - Canada
Vice-Chair: Noam Yarom, DMD - Israel
Research Lead: Kıvanç Bektaş Kayhan, PhD, DDS - Turkey
Systematic Review Lead: Derek K. Smith, DDS, PhD – United States

Palliative Care
The Palliative Care Study Group seeks to foster international collaborations related to education and research in supportive and palliative oncology in order to improve the quality of cancer care. Recent research includes a Delphi survey to develop an international consensus on indicators for the integration of specialty palliative care and oncology programs for hospitalized advanced cancer patients.
Chair: Gregory Crawford, MD - Australia
Vice-Chair: Sandip Mukhopadhyay, MD - India

Subgroup: Cancer Pain
Leadership: Mellar Davis, MD - USA,  Akhila Reddy, MD – USA

The Pediatrics Study Group works to bridge the gap between research and clinical practice as it applies to children with cancer, for example by developing and updating guidelines for the supportive care of children with cancer. A current project involves updating guidelines for the care of children in the Netherlands.
Chair: Andrea Orsey, MD, MSCE – United States
Vice-Chair: Jason Freedman, MD MSCE – United States

The Psychosocial Study Group aims to make the psychosocial dimensions of care, including appropriate assessment and interventions, an integral part of routine cancer care for all patients. The group serves as a resource to MASCC members, helping to raise awareness of psychosocial issues and meet members’ needs regarding aspects of psychosocial oncology. 
Chair: Bogda Koczwara, AM, BM, BS, FRACP, MBioethics, FAICD - Australia
Vice-Chair: Bethany Andrews Rhoten, PhD, RN - United States

The Survivorship Study Group works to optimize wellness by improving outcomes for cancer survivors. The Study Group fosters research and educational initiatives, develops clinical guidelines, raises awareness about survivorship issues and resources, and fosters professional development of junior researchers in the field.
Chair: Raymond Chan, PhD, MAppSc, BN, RN, FACN - Australia
Vice-Chair: Margaret Fitch, RN, PhD - Canada

Subgroup: Exercise Oncology